BAMCO Inc
INBX

BAMCO Inc’s Inhibrx, Inc. Common Stock INBX Stock Holding History

BAMCO Inc’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-30,000
Closed -$779K – 352
2023
Q2 		$779K Sell
30,000
-12,500
-29% -$292K ﹤0.01% 317
2023
Q1 		$802K Sell
42,500
-27,500
-39% -$640K ﹤0.01% 326
2022
Q4 		$1.72M Buy
+70,000
New +$2.06M 0.01% 316

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BAMCO Inc's INBX Position: Q3 2023 in Review

BAMCO Inc sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2023, closing a stake of 30,000 shares — an estimated $779K sold.

BAMCO Inc first reported a position in INBX in Q4 2022 and held it in 3 quarters. The position peaked at $1.72M in Q4 2022. 110 funds tracked by Wall St. Rank hold INBX as of Q3 2023.

  • BAMCO Inc reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • BAMCO Inc sold 30,000 Inhibrx, Inc. Common Stock shares in Q3 2023, an estimated $779K.
  • BAMCO Inc first reported a position in Inhibrx, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • BAMCO Inc's Inhibrx, Inc. Common Stock position peaked at $1.72M in Q4 2022.
  • 110 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2023.

Based on BAMCO Inc's 13F filing for Q3 2023, filed 14 Nov 2023.